The safety of a nurse-led day case cardioversion service in the novel oral anticoagulant era: a single centre experience

2015 ◽  
Vol 24 ◽  
pp. S233
Author(s):  
P. Moore ◽  
N. Lollback ◽  
L. Slater ◽  
P. Gould ◽  
J. Hill ◽  
...  
2015 ◽  
Vol 57 ◽  
pp. 215
Author(s):  
Maria Hoeltzenbein ◽  
Evelin Wacker ◽  
Katja Meixner ◽  
Reinhold Kreutz ◽  
Christof Schaefer

Author(s):  
Jurica Arapović ◽  
Siniša Skočibušić

The novel coronavirus disease 2019 (COVID-19) pandemic caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is still progressing and has been recorded in more than 210 countries and territories worldwide. In Bosnia and Herzegovina, the first cases of COVID-19 were detected on 5th of March 2020 in the entity of Republic of Srpska and 9th of March 2020 in the entity of Federation of Bosnia and Herzegovina. Up until the 16th of May 2020, more than 2,200 COVID-19 cases were recorded in both entities, with a mortality rate of 5.8% (131 out of 2231 cases). The aim of this ongoing study is to present the current epidemiological and sociodemographic parameters of 380 COVID-19 patients diagnosed at the University Clinical Hospital Mostar (UCH Mostar) during the first two months of the COVID-19 pandemic. Out of 380 patients, 60 (15.8%) of them required hospitalization. The mortality rate was 5% (19/380). The highest mortality rate of 15.2% (12/79) was recorded in the patients age ≥65 years. In addition to this single-centre experience of the ongoing COVID-19 pandemic, we discuss the epidemiological measures imposed in Bosnia and Herzegovina, with emphasis on the restrictive ones. The COVID-19 pandemic is still ongoing in Bosnia and Herzegovina.


EP Europace ◽  
2017 ◽  
Vol 19 (suppl_1) ◽  
pp. i19-i19 ◽  
Author(s):  
S Bartoletti ◽  
M Mann ◽  
A Khan ◽  
A Sahni ◽  
M El-Kadri ◽  
...  

Gut ◽  
2013 ◽  
Vol 62 (Suppl 1) ◽  
pp. A273.1-A273
Author(s):  
L Tobin ◽  
O D Patani ◽  
S Hood ◽  
R Sturgess ◽  
N Stern

2017 ◽  
Vol 2017 ◽  
pp. 1-4
Author(s):  
Kirk Bowling ◽  
Samantha Leong ◽  
Sarah El-Badawy ◽  
Erfan Massri ◽  
Jaideep Rait ◽  
...  

Aim. The purpose of this study was to evaluate whether patients with a high BMI can undergo safe day case LC for cholecystitis compared to groups of patients with a lower BMI. Setting. NHS District General Hospital, UK. Methods. A retrospective review of 2391 patients who underwent an attempted day case LC between 1 January 2009 and 15 August 2015 was performed. Patients were divided into five groups depending on their BMI. Inclusion criteria were patients undergoing elective day case laparoscopic cholecystectomy with cholecystitis on histology. The endpoints were complication requiring readmission and postoperative length of stay (LOS). Results. There were 2391 LCs performed in the time period of which 1646 were eligible for inclusion. These LCs were classified as 273 (16.9%), 608 (37.8%), 428 (26.6%), 208 (12.9%), and 91 (5.66%) patients in the groups with BMI values of 18.5–24.9, 25–29.9, 30–34.9, 35–39.9, and >40, respectively. Average BMI was 30.0 (±5.53, 19–51) with an average postoperative LOS of 0.86, and there was no difference between the BMI groups. Overall complication rate was 4.3%; there was no significance between BMI groups. Conclusions. Increased BMI was not associated with worse outcomes after day case LC.


2011 ◽  
Vol 39 (3) ◽  
pp. 23-34 ◽  
Author(s):  
Ryan Wilcox ◽  
Robert C. Pendleton ◽  
Kristi J. Smock ◽  
George M. Rodgers

Sign in / Sign up

Export Citation Format

Share Document